Treatment of Bacterial Conjunctivitis: Frequency and Duration

Treatment Approach Based on Severity

For mild bacterial conjunctivitis, a 5- to 7-day course of a broad-spectrum topical antibiotic applied 4 times daily is the recommended treatment regimen, with the most convenient or least expensive option being appropriate as there is no clinical evidence suggesting superiority of any particular antibiotic 1, 2, 3
Mild bacterial conjunctivitis is typically self-limited and may resolve spontaneously without treatment in immunocompetent adults 4
Topical antibacterial therapy is associated with earlier clinical and microbiological remission, reduced transmissibility, and earlier return to school for children 1, 4
The American Academy of Ophthalmology recommends a 5-7 day course of broad-spectrum topical antibiotic for mild bacterial conjunctivitis, with the most convenient or least expensive option being appropriate 1, 2, 3

Moderate to severe bacterial conjunctivitis is characterized by copious purulent discharge, pain, and marked inflammation, and requires more aggressive treatment approach 1, 3
Conjunctival cultures and Gram staining should be obtained if gonococcal infection is suspected, and the choice of antibiotic should be guided by laboratory test results 1
Compounded topical antibiotics, such as vancomycin, may be required in cases of resistant organisms like MRSA 1, 4

Gonococcal conjunctivitis requires systemic antibiotic therapy, daily follow-up until resolution of conjunctivitis, and topical treatment as for bacterial keratitis if corneal involvement is present 1, 3
Chlamydial conjunctivitis requires systemic therapy, especially in infants who may have infection at other sites, and follow-up evaluation is important as treatment failure can occur in up to 19% of cases 5

Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotic therapy and could be considered when access to antibiotics is limited 1, 6

Increasing bacterial resistance is a concern, particularly with methicillin-resistant S. aureus (MRSA), and for children with gonococcal or chlamydial infections, consider the possibility of sexual abuse 1, 3